PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 2 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
BRIEF published on 02/28/2024 at 07:30, 2 years 2 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 7 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 8 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 8 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 8 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 2 years 10 months ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 2 years 11 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
PRESS RELEASE published on 05/25/2023 at 07:30, 3 years ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
PRESS RELEASE published on 05/24/2023 at 09:30, 3 years ago BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
Published on 05/27/2026 at 15:25, 2 hours 3 minutes ago LaFleur Announces Upsize of Bought Deal Equity Offerings for Gross Proceeds of C$10 Million
Published on 05/27/2026 at 15:22, 2 hours 6 minutes ago AmeriTrust Announces First Quarter 2026 Financial Results
Published on 05/27/2026 at 15:15, 2 hours 13 minutes ago Storm Exploration Begins Field Program on VMS Target at Gold Standard
Published on 05/27/2026 at 15:00, 2 hours 28 minutes ago Jaguar Health Compliant with Nasdaq Bid Price Rule
Published on 05/27/2026 at 14:49, 2 hours 39 minutes ago Sekur Private Data Signs Defense Distribution Agreement with Elyon International, Marking Strategic Shift to Defense, Government and Enterprise Communications
Published on 05/27/2026 at 17:02, 26 minutes ago EQS-Adhoc: HMS Bergbau AG: HMS Bergbau publishes forecast for 2026 – significant growth expected in revenue and operating profit
Published on 05/27/2026 at 16:45, 43 minutes ago Onlineprinters posts strong increase in revenues and profitability in the first quarter of 2026
Published on 05/27/2026 at 16:37, 51 minutes ago EQS-Adhoc: Verbio SE: Verbio increases EBITDA forecast for the financial year 2025/2026 again
Published on 05/27/2026 at 16:10, 1 hour 18 minutes ago Michter's Announces 2026 Release of Its Coveted 10 Year Rye
Published on 05/27/2026 at 11:51, 5 hours 37 minutes ago Statement of transactions in own shares from May 18, 2026 to May 22, 2026
Published on 05/26/2026 at 18:39, 22 hours 48 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 23 hours 43 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
